{"id":1853,"date":"2026-06-27T12:37:55","date_gmt":"2026-06-27T11:37:55","guid":{"rendered":"http:\/\/seamlessbio.de\/?page_id=1853"},"modified":"2026-06-27T12:38:19","modified_gmt":"2026-06-27T11:38:19","slug":"switching-human-serum-supplier","status":"publish","type":"page","link":"https:\/\/seamlessbio.de\/de\/switching-human-serum-supplier\/","title":{"rendered":"Resources switching Human Serum Supplier"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1853\" class=\"elementor elementor-1853\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-63b2b82 e-con e-atomic-element e-flexbox-base e-689c577 \" data-id=\"63b2b82\" data-element_type=\"e-flexbox\" data-e-type=\"e-flexbox\" data-interaction-id=\"63b2b82\">\n    \t\t<div class=\"elementor-element elementor-element-29c55ec elementor-widget elementor-widget-html\" data-id=\"29c55ec\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<!-- YOAST SEO SETTINGS\nSlug:             resources\/switching-human-serum-supplier\nFocus Keyword:    switching human serum supplier EU IVDR IVD lot consistency batch reservation\nSEO Title (EN):   Switching Human Serum Supplier \u2014 The 7 Criteria That Actually Matter | SeamlessBio\nMeta Desc (EN):   Expert guide to switching human serum suppliers. 7 criteria: EU donor origin, viral screening, lot consistency, batch reservation, documentation, volume flexibility, supply security. SeamlessBio.\n-->\n<section class=\"sb-app\">\n<style>\n.sb-app,.sb-app *,.sb-app *::before,.sb-app *::after{box-sizing:border-box;}\n.sb-app{background:#fff;padding:70px 40px 90px;font-family:Arial,sans-serif;color:#202020;}\n.sb-app .wrap{max-width:1200px;width:100%;margin:0 auto;}\n.sb-app .bc{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 24px;color:#777;font-size:14px;}\n.sb-app .bc a{color:#18b7b2!important;text-decoration:none!important;font-weight:700;}\n.sb-app .bc strong{color:#111;font-weight:800;}\n.sb-app .hero{padding:64px 56px;margin-bottom:48px;border-radius:30px;background:linear-gradient(135deg,#18b7b2 0%,#65d3cf 52%,#e9fbfa 100%);color:#fff;}\n.sb-app .hero .ey{display:inline-block;margin-bottom:14px;font-size:13px;font-weight:900;text-transform:uppercase;letter-spacing:1.8px;}\n.sb-app .hero h1{margin:0 0 18px;color:#fff;font-size:clamp(26px,3.2vw,40px);line-height:1.1;font-weight:900;letter-spacing:-1px;max-width:840px;}\n.sb-app .hero .sub{max-width:720px;margin:0 0 30px;color:#fff;font-size:17px;line-height:1.65;}\n.sb-app .hbtns{display:flex;flex-wrap:wrap;gap:14px;}\n.sb-app .btn1{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;background:#18b7b2;color:#fff!important;text-decoration:none!important;text-transform:uppercase;font-size:13px;font-weight:900;letter-spacing:.6px;transition:all .25s;}\n.sb-app .btn1:hover{background:#139b97;transform:translateY(-2px);}\n.sb-app .btn2{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;background:transparent;border:2px solid #fff;color:#fff!important;text-decoration:none!important;text-transform:uppercase;font-size:13px;font-weight:900;letter-spacing:.6px;transition:all .25s;}\n.sb-app .btn2:hover{background:#fff;color:#139b97!important;transform:translateY(-2px);}\n.sb-app .note{background:rgba(24,183,178,.08);border-left:4px solid #18b7b2;border-radius:8px;padding:18px 22px;margin-bottom:32px;font-size:14px;color:#444;line-height:1.7;}\n.sb-app .note strong{color:#111;display:block;margin-bottom:6px;font-size:15px;}\n\/* Criteria cards *\/\n.sb-app .crit-grid{display:grid;grid-template-columns:repeat(2,1fr);gap:18px;margin-bottom:40px;}\n.sb-app .crit{border:1.5px solid rgba(24,183,178,.2);border-radius:20px;padding:26px;background:#f7fbfb;transition:all .22s;}\n.sb-app .crit:hover{border-color:#18b7b2;box-shadow:0 8px 24px rgba(24,183,178,.12);}\n.sb-app .crit-num{font-size:13px;font-weight:900;color:#18b7b2;margin-bottom:10px;}\n.sb-app .crit h3{font-size:16px;font-weight:900;color:#111;margin:0 0 10px;}\n.sb-app .crit p{font-size:13px;color:#555;line-height:1.65;margin:0 0 10px;}\n.sb-app .crit .ask{font-size:12px;color:#18b7b2;font-weight:700;background:rgba(24,183,178,.08);padding:8px 12px;border-radius:8px;display:block;}\n\/* Checklist *\/\n.sb-app .checklist{background:#f7fbfb;border:1px solid rgba(24,183,178,.18);border-radius:18px;padding:28px 32px;margin-bottom:34px;}\n.sb-app .checklist h3{font-size:18px;font-weight:900;color:#111;margin:0 0 18px;}\n.sb-app .ci{display:flex;gap:14px;align-items:flex-start;padding:10px 0;border-bottom:1px solid #eee;}\n.sb-app .ci:last-child{border-bottom:none;}\n.sb-app .ci-dot{width:22px;height:22px;border-radius:50%;background:#18b7b2;color:#fff;font-size:10px;font-weight:900;display:flex;align-items:center;justify-content:center;flex-shrink:0;margin-top:2px;}\n.sb-app .ci p{font-size:14px;color:#444;line-height:1.65;margin:0;}\n.sb-app .ci strong{color:#111;}\n.sb-app .sec{margin-bottom:34px;padding:34px;border-radius:26px;background:#fff;border:1px solid #eee;}\n.sb-app .sec h2{margin:0 0 14px;color:#111;font-size:22px;font-weight:900;}\n.sb-app .sec p{margin:0 0 12px;color:#555;font-size:15px;line-height:1.7;}\n.sb-app .tw{overflow-x:auto;margin-top:16px;}\n.sb-app table{width:100%;border-collapse:collapse;font-size:14px;min-width:480px;}\n.sb-app thead th{background:#18b7b2;color:#fff;padding:11px 13px;text-align:left;font-weight:700;}\n.sb-app tbody tr:nth-child(even){background:#f5fffe;}\n.sb-app tbody tr:hover{background:#e8f9f8;}\n.sb-app tbody td{padding:10px 13px;vertical-align:top;border-bottom:1px solid #e5e5e5;line-height:1.5;font-size:13px;}\n.sb-app table a{color:#18b7b2;text-decoration:none;font-weight:600;}\n.sb-app .ok{color:#18b7b2;font-weight:700;}\n\/* SeamlessBio box *\/\n.sb-app .sb-box{background:#111;border-radius:22px;padding:34px 38px;margin-bottom:34px;display:grid;grid-template-columns:1fr auto;gap:28px;align-items:center;}\n.sb-app .sb-box h3{color:#fff;font-size:18px;font-weight:900;margin:0 0 12px;}\n.sb-app .sb-box ul{margin:0;padding:0;list-style:none;}\n.sb-app .sb-box li{font-size:13px;color:rgba(255,255,255,.8);padding:5px 0 5px 18px;position:relative;}\n.sb-app .sb-box li::before{content:\"\";position:absolute;left:0;top:13px;width:7px;height:7px;border-radius:50%;background:#18b7b2;}\n.sb-app .sb-box li strong{color:#18b7b2;}\n.sb-app .sb-btns{display:flex;flex-direction:column;gap:10px;flex-shrink:0;}\n.sb-app .sb-btn{display:inline-flex;align-items:center;justify-content:center;min-width:180px;min-height:44px;padding:0 20px;border-radius:999px;font-size:12px;font-weight:900;text-decoration:none!important;text-transform:uppercase;letter-spacing:.5px;transition:all .2s;}\n.sb-app .sb-btn1{background:#18b7b2;color:#fff!important;}\n.sb-app .sb-btn1:hover{background:#139b97;}\n.sb-app .sb-btn2{background:transparent;color:#fff!important;border:1.5px solid rgba(255,255,255,.3);}\n.sb-app .sb-btn2:hover{background:rgba(255,255,255,.08);}\n.sb-app .faq{margin-bottom:34px;padding:34px;border-radius:26px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);}\n.sb-app .faq h2{margin:0 0 20px;color:#111;font-size:22px;font-weight:900;}\n.sb-app .faq-item{border-bottom:1px solid #e0e0e0;padding:18px 0;}\n.sb-app .faq-item:last-child{border-bottom:none;padding-bottom:0;}\n.sb-app .faq-q{font-size:15px;font-weight:900;color:#111;margin-bottom:8px;}\n.sb-app .faq-a{font-size:14px;color:#555;line-height:1.7;}\n.sb-app .related{margin-bottom:34px;padding:28px 34px;border-radius:26px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);}\n.sb-app .related h3{margin:0 0 16px;color:#111;font-size:18px;font-weight:900;}\n.sb-app .rel-grid{display:grid;grid-template-columns:repeat(2,1fr);gap:12px;}\n.sb-app .rel-grid a{display:flex;align-items:center;min-height:50px;padding:12px 16px;border-radius:12px;background:#fff;border:1px solid #e0e0e0;color:#111!important;text-decoration:none!important;font-size:13px;font-weight:700;transition:all .2s;}\n.sb-app .rel-grid a:hover{border-color:#18b7b2;color:#139b97!important;}\n.sb-app .hub-back{text-align:center;padding:20px 0 0;border-top:1px solid rgba(24,183,178,.15);margin-bottom:16px;}\n.sb-app .hub-back a{color:#18b7b2;font-size:14px;font-weight:700;text-decoration:none;}\n.sb-app .cta{padding:54px 34px;border-radius:30px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);text-align:center;}\n.sb-app .cta h2{margin:0 0 12px;color:#111;font-size:28px;font-weight:900;}\n.sb-app .cta p{max-width:760px;margin:0 auto 26px;color:#555;font-size:15px;line-height:1.65;}\n.sb-app .ctabtns{display:flex;flex-wrap:wrap;gap:14px;justify-content:center;}\n.sb-app .ctab1,.sb-app .ctab2{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;font-size:13px;font-weight:900;text-transform:uppercase;letter-spacing:.6px;text-decoration:none!important;transition:all .25s;}\n.sb-app .ctab1{background:#18b7b2;color:#fff!important;}\n.sb-app .ctab1:hover{background:#139b97;transform:translateY(-2px);}\n.sb-app .ctab2{background:transparent;border:2px solid #18b7b2;color:#18b7b2!important;}\n.sb-app .ctab2:hover{background:#18b7b2;color:#fff!important;transform:translateY(-2px);}\n@media(max-width:1100px){.sb-app .hero{padding:48px 36px;}.sb-app .crit-grid{grid-template-columns:1fr;}.sb-app .sb-box{grid-template-columns:1fr;}.sb-app .rel-grid{grid-template-columns:1fr;}}\n@media(max-width:700px){.sb-app{padding:50px 16px 70px;}.sb-app .hero{padding:40px 24px;border-radius:24px;}.sb-app .hero h1{font-size:25px;}.sb-app .hbtns,.sb-app .ctabtns{flex-direction:column;}.sb-app .btn1,.sb-app .btn2,.sb-app .ctab1,.sb-app .ctab2{width:100%;}.sb-app .checklist,.sb-app .sec,.sb-app .faq{padding:20px;}.sb-app .cta{padding:36px 20px;}}\n<\/style>\n<div class=\"wrap\">\n  <div class=\"bc\">\n    <a href=\"http:\/\/seamlessbio.de\/\">Home<\/a><span>\/<\/span>\n    <a href=\"https:\/\/www.seamlessbio.de\/applications\/\">Applications<\/a><span>\/<\/span>\n    <strong>Switching Human Serum Supplier<\/strong>\n  <\/div>\n  <div class=\"hero\">\n    <span class=\"ey\">SeamlessBio \u2014 IVD \u00b7 Cell Culture \u00b7 IVDR \u00b7 EU Donor Origin<\/span>\n    <h1>Switching Human Serum Supplier \u2014 The 7 Criteria That Actually Matter<\/h1>\n    <p class=\"sub\">Whether you are moving because of supply issues, documentation gaps, pricing, or regulatory requirements \u2014 switching human serum is not a decision to take lightly. This guide covers the seven criteria experienced IVD developers and cell culture teams use to evaluate and qualify a new supplier.<\/p>\n    <div class=\"hbtns\">\n      <a href=\"mailto:info@seamlessbio.de\" class=\"btn1\">Request Free Test Samples<\/a>\n      <a href=\"https:\/\/shop.seamlessbio.de\/collections\/humanserum-plasma-und-mehr\" class=\"btn2\">Browse Human Sera \u2192<\/a>\n    <\/div>\n  <\/div>\n\n  <!-- 7 CRITERIA -->\n  <div class=\"crit-grid\">\n    <div class=\"crit\">\n      <div class=\"crit-num\">Criterion 1<\/div>\n      <h3>Donor Origin &amp; Regulatory Framework<\/h3>\n      <p>For European IVD manufacturers under EU IVDR 2017\/746, donor origin directly affects regulatory documentation. EU-qualified donors processed under EU Blood Directive 2002\/98\/EC provide the cleanest path through your technical file. US-origin material is not disqualified \u2014 but requires additional justification in a European regulatory submission.<\/p>\n      <span class=\"ask\">Ask your supplier: \"What country are your donors from and under which regulatory framework are they qualified?\"<\/span>\n    <\/div>\n    <div class=\"crit\">\n      <div class=\"crit-num\">Criterion 2<\/div>\n      <h3>Donor Screening Panel<\/h3>\n      <p>Minimum screening must include HIV 1\/2 (antibody and NAT), HBsAg, anti-HCV (and HCV RNA), syphilis and HTLV I\/II where applicable. For IVD applications, request the full screening certificate \u2014 not just a CoA summary. Extended panels (HAV, HEV, B19 parvovirus) are relevant for specific assay types.<\/p>\n      <span class=\"ask\">Ask your supplier: \"Can you provide the full donor screening panel with NAT results for each lot?\"<\/span>\n    <\/div>\n    <div class=\"crit\">\n      <div class=\"crit-num\">Criterion 3<\/div>\n      <h3>Lot-to-Lot Consistency &amp; Batch Reservation<\/h3>\n      <p>Human serum is a biological material \u2014 inherent lot variability is unavoidable. The question is how your supplier manages it. Batch reservation \u2014 the ability to reserve a validated lot and call it off over time \u2014 is the single most important operational tool for managing consistency in long-term projects.<\/p>\n      <span class=\"ask\">Ask your supplier: \"Can I reserve a specific lot without prepayment and call it off in partial deliveries?\"<\/span>\n    <\/div>\n    <div class=\"crit\">\n      <div class=\"crit-num\">Criterion 4<\/div>\n      <h3>Documentation Quality<\/h3>\n      <p>A CoA is the minimum. For IVD development and GMP applications you also need: origin certificate, donor screening records, sterility test results, processing batch records, and ideally a technical file or DMF number for regulatory submissions. Suppliers who cannot provide this within 48 hours are a red flag.<\/p>\n      <span class=\"ask\">Ask your supplier: \"What documentation do you supply per lot, and what is available on request?\"<\/span>\n    <\/div>\n    <div class=\"crit\">\n      <div class=\"crit-num\">Criterion 5<\/div>\n      <h3>Processing Options &amp; Variants<\/h3>\n      <p>Native, heat inactivated, delipidated, IgG-depleted, charcoal stripped, gamma irradiated \u2014 the range of processing options determines whether a supplier can serve your full application portfolio or only part of it. Sourcing multiple variants from a single supplier reduces qualification burden.<\/p>\n      <span class=\"ask\">Ask your supplier: \"Which processing variants do you have in stock vs. available on request, and what are lead times?\"<\/span>\n    <\/div>\n    <div class=\"crit\">\n      <div class=\"crit-num\">Criterion 6<\/div>\n      <h3>Volume Flexibility &amp; No Minimum Orders<\/h3>\n      <p>Development teams need small quantities for method development and validation. Production teams need reliable large-volume supply. A supplier that requires large minimum orders forces overstocking or dual-sourcing. No minimum order quantity with flexible volume options is the ideal setup for both phases.<\/p>\n      <span class=\"ask\">Ask your supplier: \"What is the minimum order quantity, and can I order 100 mL for initial validation?\"<\/span>\n    <\/div>\n    <div class=\"crit\">\n      <div class=\"crit-num\">Criterion 7<\/div>\n      <h3>Supply Security &amp; Lead Times<\/h3>\n      <p>Human serum supply depends on donor availability. Supply disruptions are more common than anticipated \u2014 particularly for rare formats like delipidated, IgG-free, or male-only serum. A supplier with EU stock, short lead times, and clear batch reservation policy significantly reduces supply chain risk.<\/p>\n      <span class=\"ask\">Ask your supplier: \"Where is the stock held, what are typical lead times, and what happens if my reserved lot runs out?\"<\/span>\n    <\/div>\n    <div class=\"crit\" style=\"border-color:rgba(24,183,178,.4);background:rgba(24,183,178,.05);\">\n      <div class=\"crit-num\" style=\"color:#111;\">Bonus<\/div>\n      <h3>Personal Service &amp; Technical Support<\/h3>\n      <p>A named contact who answers technical questions, understands your application, and resolves supply issues directly \u2014 without call centres or ticket systems \u2014 is not a luxury in a regulated supply chain. It is a risk management tool.<\/p>\n      <span class=\"ask\" style=\"color:#111;background:#fff;\">SeamlessBio: direct contact in Passau \u00b7 info@seamlessbio.de \u00b7 +49 851 37932226<\/span>\n    <\/div>\n  <\/div>\n\n  <!-- SWITCHING CHECKLIST -->\n  <div class=\"checklist\">\n    <h3>Supplier Switching Checklist \u2014 Before You Commit<\/h3>\n    <div class=\"ci\"><div class=\"ci-dot\">\u2713<\/div><p><strong>Request test samples of at least 2 different lots<\/strong> \u2014 not just 1. Single-lot evaluation does not reveal batch variability.<\/p><\/div>\n    <div class=\"ci\"><div class=\"ci-dot\">\u2713<\/div><p><strong>Run a parallelism study<\/strong> \u2014 test new supplier lot against your current validated lot side-by-side in your assay or cell culture system.<\/p><\/div>\n    <div class=\"ci\"><div class=\"ci-dot\">\u2713<\/div><p><strong>Define acceptance criteria before testing<\/strong> \u2014 not after. Minimum cell growth %, maximum CV between lots, minimum analyte recovery in your assay.<\/p><\/div>\n    <div class=\"ci\"><div class=\"ci-dot\">\u2713<\/div><p><strong>Request full documentation upfront<\/strong> \u2014 CoA, donor screening, origin certificate. If the supplier hesitates, that tells you something.<\/p><\/div>\n    <div class=\"ci\"><div class=\"ci-dot\">\u2713<\/div><p><strong>Clarify batch reservation terms<\/strong> \u2014 volume, timeline, prepayment requirements, what happens if the reserved lot is exhausted.<\/p><\/div>\n    <div class=\"ci\"><div class=\"ci-dot\">\u2713<\/div><p><strong>Overlap your supply<\/strong> \u2014 maintain sufficient stock of the old lot during validation of the new lot. Never switch mid-project without a validated alternative.<\/p><\/div>\n    <div class=\"ci\"><div class=\"ci-dot\">\u2713<\/div><p><strong>Document the switch<\/strong> \u2014 for GMP and IVD applications, a supplier change is a documented change control event. Prepare your comparability report before initiating the switch.<\/p><\/div>\n  <\/div>\n\n  <!-- CRITERIA BY APPLICATION -->\n  <div class=\"sec\">\n    <h2>Which Criteria Matter Most \u2014 By Application<\/h2>\n    <div class=\"tw\">\n      <table>\n        <thead><tr><th>Application<\/th><th>Most Critical Criteria<\/th><th>Key Format<\/th><\/tr><\/thead>\n        <tbody>\n          <tr><td>CAR-T \/ ATMP manufacturing<\/td><td>EU origin, GMP documentation, lot reservation, xeno-free path<\/td><td>Human Serum AB OTC Male<\/td><\/tr>\n          <tr><td>IVD assay development<\/td><td>Donor screening documentation, lot consistency, matrix matching<\/td><td>Universal Negative, Delipidated<\/td><\/tr>\n          <tr><td>Lipemia interference studies<\/td><td>Delipidation method, residual lipid specification, CLSI EP7<\/td><td>Delipidated Human Serum<\/td><\/tr>\n          <tr><td>Hormone \/ steroid assays<\/td><td>Charcoal stripping completeness, hormone-free certificate<\/td><td>Double Charcoal Treated<\/td><\/tr>\n          <tr><td>Malaria \/ P. falciparum culture<\/td><td>Type AB mandatory, lot qualification by parasitaemia assay<\/td><td>Human Serum AB OTC<\/td><\/tr>\n          <tr><td>Hybridoma production<\/td><td>Complement inactivation, IgG background level<\/td><td>Human Serum AB HI<\/td><\/tr>\n          <tr><td>MSC expansion (clinical)<\/td><td>Xeno-free, EU origin, GMP documentation, lot reservation<\/td><td>Human Serum AB or hPL<\/td><\/tr>\n        <\/tbody>\n      <\/table>\n    <\/div>\n  <\/div>\n\n  <!-- WHY SEAMLESSBIO -->\n  <div class=\"sb-box\">\n    <div>\n      <h3>Why labs switch to SeamlessBio for human serum<\/h3>\n      <ul>\n        <li><strong>EU-qualified donors<\/strong> \u2014 processed under EU Blood Directive 2002\/98\/EC, directly relevant for IVDR technical documentation<\/li>\n        <li><strong>Batch reservation without prepayment<\/strong> \u2014 reserve your validated lot, call off in partial deliveries as needed<\/li>\n        <li><strong>No minimum order quantity<\/strong> \u2014 100 mL for validation, bulk for production \u2014 same supplier, same lot<\/li>\n        <li><strong>Full documentation per lot<\/strong> \u2014 CoA, donor screening records, origin certificate, viral testing panel<\/li>\n        <li><strong>Full portfolio<\/strong> \u2014 native, heat inactivated, delipidated, Universal Negative, hPL \u2014 all from EU donors<\/li>\n        <li><strong>Direct contact<\/strong> \u2014 personal support from Passau, no call centre, no ticket system<\/li>\n      <\/ul>\n    <\/div>\n    <div class=\"sb-btns\">\n      <a href=\"mailto:info@seamlessbio.de\" class=\"sb-btn sb-btn1\">Request test samples \u2192<\/a>\n      <a href=\"https:\/\/shop.seamlessbio.de\/collections\/humanserum-plasma-und-mehr\" class=\"sb-btn sb-btn2\">Browse products \u2192<\/a>\n    <\/div>\n  <\/div>\n\n  <!-- FAQ -->\n  <div class=\"faq\">\n    <h2>Frequently Asked Questions<\/h2>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">How long does a human serum supplier switching study typically take?<\/div>\n      <div class=\"faq-a\">For cell culture applications: 3\u20136 weeks \u2014 1\u20132 weeks for parallel culture comparison, 2\u20133 weeks for functional assay validation and data review. For IVD applications under IVDR, the formal comparability study and change documentation takes 6\u201312 weeks depending on your internal change control process. We recommend testing samples from at least 2 different SeamlessBio lots to include inter-lot variability in your evaluation.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">Can I test SeamlessBio human serum against my current supplier before committing?<\/div>\n      <div class=\"faq-a\">Yes \u2014 free test samples are available for all human serum variants. Contact info@seamlessbio.de or +49 851 37932226. We recommend testing at least two lots side-by-side against your current reference. Batch reservation is available without prepayment once your switching study is complete.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">What documentation does SeamlessBio provide for IVDR technical files?<\/div>\n      <div class=\"faq-a\">Per lot: Certificate of Analysis (CoA), donor screening records (HIV 1\/2, HBsAg, HCV, syphilis \u2014 with NAT results), origin certificate confirming EU donor qualification under EU Blood Directive 2002\/98\/EC, sterility test results and processing documentation. Extended documentation for GMP or IVDR submissions available on request.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">Is batch reservation available without minimum order quantities?<\/div>\n      <div class=\"faq-a\">Yes \u2014 SeamlessBio offers batch reservation for all human serum products without prepayment and without minimum order quantity. Once you have validated a lot in your system, we hold it in EU stock and release volumes as you need them \u2014 from 100 mL development quantities through to multi-litre production volumes.<\/div>\n    <\/div>\n  <\/div>\n\n  <div class=\"related\">\n    <h3>Related Applications &amp; Products<\/h3>\n    <div class=\"rel-grid\">\n      <a href=\"https:\/\/www.seamlessbio.de\/applications\/pbmc-immunology\">\u2192 PBMC &amp; Immunology Assay Guide<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/applications\/car-t-cell-manufacturing\">\u2192 CAR-T Cell Manufacturing Guide<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/applications\/malaria-tropical-disease-research\">\u2192 Malaria &amp; Tropical Disease Research<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab-male\">\u2192 Human Serum AB OTC Male<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-type-ab-male\">\u2192 Human Serum AB HI<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-delipidated\">\u2192 Human Serum Delipidated<\/a>\n    <\/div>\n  <\/div>\n  <div class=\"hub-back\"><a href=\"https:\/\/www.seamlessbio.de\/applications\/\">\u2190 All Application Guides Overview<\/a><\/div>\n  <div class=\"cta\">\n    <h2>Ready to Evaluate SeamlessBio Human Serum?<\/h2>\n    <p>Free test samples, no minimum order, batch reservation without prepayment. EU stock in Passau \u2014 fast delivery across EU and UK. Response within 1 business day.<br>Email: info@seamlessbio.de | +49 851 37932226<\/p>\n    <div class=\"ctabtns\">\n      <a href=\"mailto:info@seamlessbio.de\" class=\"ctab1\">Request Free Samples<\/a>\n      <a href=\"https:\/\/shop.seamlessbio.de\/collections\/humanserum-plasma-und-mehr\" class=\"ctab2\">Browse All Human Sera<\/a>\n    <\/div>\n  <\/div>\n<\/div>\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"FAQPage\",\n      \"@id\": \"https:\/\/www.seamlessbio.de\/resources\/switching-human-serum-supplier#faqpage\",\n      \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How long does a human serum supplier switching study typically take?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"For cell culture applications: 3\u20136 weeks \u2014 1\u20132 weeks for parallel culture comparison, 2\u20133 weeks for functional assay validation and data review. For IVD applications under IVDR, the formal comparability study and change documentation takes 6\u201312 weeks depending on your internal change control process. We recommend testing samples from at least 2 different SeamlessBio lots to include inter-lot variability in your evaluation.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Can I test SeamlessBio human serum against my current supplier before committing?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Yes \u2014 free test samples are available for all human serum variants. Contact info@seamlessbio.de or +49 851 37932226. We recommend testing at least two lots side-by-side against your current reference. Batch reservation is available without prepayment once your switching study is complete.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What documentation does SeamlessBio provide for IVDR technical files?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Per lot: Certificate of Analysis (CoA), donor screening records (HIV 1\/2, HBsAg, HCV, syphilis \u2014 with NAT results), origin certificate confirming EU donor qualification under EU Blood Directive 2002\/98\/EC, sterility test results and processing documentation. Extended documentation for GMP or IVDR submissions available on request.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is batch reservation available without minimum order quantities?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Yes \u2014 SeamlessBio offers batch reservation for all human serum products without prepayment and without minimum order quantity. Once you have validated a lot in your system, we hold it in EU stock and release volumes as you need them \u2014 from 100 mL development quantities through to multi-litre production volumes.\"\n      }\n    }\n      ]\n    },\n    {\n      \"@type\": \"BreadcrumbList\",\n      \"@id\": \"https:\/\/www.seamlessbio.de\/resources\/switching-human-serum-supplier#breadcrumb\",\n      \"itemListElement\": [\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 1,\n          \"name\": \"Home\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/\"\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 2,\n          \"name\": \"Resources\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/resources\/\"\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 3,\n          \"name\": \"Switching Human Serum Supplier\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/resources\/switching-human-serum-supplier\"\n        }\n      ]\n    }\n  ]\n}\n<\/script>\n<\/section>\t\t\t\t<\/div>\n\t\t\n<\/div>\n\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Home\/ Applications\/ Switching Human Serum Supplier SeamlessBio \u2014 IVD \u00b7 Cell Culture \u00b7 IVDR \u00b7 EU Donor Origin Switching Human Serum Supplier \u2014 The 7 Criteria That Actually Matter Whether [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_eb_attr":"","footnotes":""},"class_list":["post-1853","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Change Human Serum Supplier \u2014 7 Criteria Matter | SeamlessBio<\/title>\n<meta name=\"description\" content=\"Expert guide to switching human serum suppliers. 7 criteria: EU donor origin, viral screening, lot consistency, batch reservation, documentation, volume flexibility, supply security. SeamlessBio.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/seamlessbio.de\/de\/switching-human-serum-supplier\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Change Human Serum Supplier \u2014 7 Criteria Matter | SeamlessBio\" \/>\n<meta property=\"og:description\" content=\"Expert guide to switching human serum suppliers. 7 criteria: EU donor origin, viral screening, lot consistency, batch reservation, documentation, volume flexibility, supply security. SeamlessBio.\" \/>\n<meta property=\"og:url\" content=\"http:\/\/seamlessbio.de\/de\/switching-human-serum-supplier\/\" \/>\n<meta property=\"og:site_name\" content=\"SeamlessBio\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-27T11:38:19+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/seamlessbio.de\\\/switching-human-serum-supplier\\\/\",\"url\":\"http:\\\/\\\/seamlessbio.de\\\/switching-human-serum-supplier\\\/\",\"name\":\"Change Human Serum Supplier \u2014 7 Criteria Matter | SeamlessBio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\"},\"datePublished\":\"2026-06-27T11:37:55+00:00\",\"dateModified\":\"2026-06-27T11:38:19+00:00\",\"description\":\"Expert guide to switching human serum suppliers. 7 criteria: EU donor origin, viral screening, lot consistency, batch reservation, documentation, volume flexibility, supply security. SeamlessBio.\",\"breadcrumb\":{\"@id\":\"http:\\\/\\\/seamlessbio.de\\\/switching-human-serum-supplier\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\\\/\\\/seamlessbio.de\\\/switching-human-serum-supplier\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/seamlessbio.de\\\/switching-human-serum-supplier\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/seamlessbio.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Resources switching Human Serum Supplier\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"name\":\"SeamlessBio\",\"description\":\"Expert for biological materials for pharma, vaccines and research organizations\",\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/seamlessbio.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\",\"name\":\"SeamlessBio\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png\",\"contentUrl\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png\",\"width\":309,\"height\":88,\"caption\":\"SeamlessBio\"},\"image\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Change Human Serum Supplier \u2014 7 Criteria Matter | SeamlessBio","description":"Expert guide to switching human serum suppliers. 7 criteria: EU donor origin, viral screening, lot consistency, batch reservation, documentation, volume flexibility, supply security. SeamlessBio.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/seamlessbio.de\/de\/switching-human-serum-supplier\/","og_locale":"de_DE","og_type":"article","og_title":"Change Human Serum Supplier \u2014 7 Criteria Matter | SeamlessBio","og_description":"Expert guide to switching human serum suppliers. 7 criteria: EU donor origin, viral screening, lot consistency, batch reservation, documentation, volume flexibility, supply security. SeamlessBio.","og_url":"http:\/\/seamlessbio.de\/de\/switching-human-serum-supplier\/","og_site_name":"SeamlessBio","article_modified_time":"2026-06-27T11:38:19+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/seamlessbio.de\/switching-human-serum-supplier\/","url":"http:\/\/seamlessbio.de\/switching-human-serum-supplier\/","name":"Change Human Serum Supplier \u2014 7 Criteria Matter | SeamlessBio","isPartOf":{"@id":"https:\/\/seamlessbio.de\/#website"},"datePublished":"2026-06-27T11:37:55+00:00","dateModified":"2026-06-27T11:38:19+00:00","description":"Expert guide to switching human serum suppliers. 7 criteria: EU donor origin, viral screening, lot consistency, batch reservation, documentation, volume flexibility, supply security. SeamlessBio.","breadcrumb":{"@id":"http:\/\/seamlessbio.de\/switching-human-serum-supplier\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["http:\/\/seamlessbio.de\/switching-human-serum-supplier\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/seamlessbio.de\/switching-human-serum-supplier\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/seamlessbio.de\/"},{"@type":"ListItem","position":2,"name":"Resources switching Human Serum Supplier"}]},{"@type":"WebSite","@id":"https:\/\/seamlessbio.de\/#website","url":"https:\/\/seamlessbio.de\/","name":"SeamlessBio","description":"Experte f\u00fcr biologische Materialien f\u00fcr die Pharmaindustrie, Impfstoffe und Forschungseinrichtungen","publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/seamlessbio.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/seamlessbio.de\/#organization","name":"SeamlessBio","url":"https:\/\/seamlessbio.de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/seamlessbio.de\/#\/schema\/logo\/image\/","url":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png","contentUrl":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png","width":309,"height":88,"caption":"SeamlessBio"},"image":{"@id":"https:\/\/seamlessbio.de\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/1853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/comments?post=1853"}],"version-history":[{"count":4,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/1853\/revisions"}],"predecessor-version":[{"id":1857,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/1853\/revisions\/1857"}],"wp:attachment":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/media?parent=1853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}